Precision NanoSystems (PNI), a biotechnology company pioneering innovative solutions for the development of genetic nanomedicines used in oncology, rare disease and infectious disease, has announced the launch of its Clinical Solutions service.

PNI is offering this new service as a response to repeated requests from clients progressing their programs towards the clinic for support across all aspects of nanomedicine clinical development. Clinical Solutions offers clients a flexible, customizable suite of products and services designed to accelerate the clinical and commercial development of Gene and Cell Therapies.

Clinical Solutions maximizes the effectiveness of clinical and commercial nanomedicine development by leveraging client capabilities and resources with Precision’s NanoAssemblr technology, nanomedicine development services, and value-added partners. The service’s flexibility enables solutions for both virtual companies and multinational Pharmaceutical organizations developing nanomedicines.

"We are dedicated to enabling the success of our client’s nanomedicine development programs", said Euan Ramsay, Chief Commercial Officer of Precision. "Clinical Solutions is designed to provide a one-stop-shop for all nanomedicine clinical development needs, such as, sourcing GMP excipients, developing analytical methods, building Quality Management Systems or accessing experienced Contract Manufacturing Organizations."

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.